Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

107 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pharmacological inhibition of mTOR attenuates DOCA-salt-induced hypertension and related pathophysiology: regulation of oxidative stress, inflammation and cardiovascular hypertrophy in male rats.
Temiz-Resitoglu M, Guden DS, Senol SP, Vezir O, Sucu N, Kibar D, Yılmaz SN, Tunctan B, Malik KU, Sahan-Firat S. Temiz-Resitoglu M, et al. Among authors: senol sp. J Cardiovasc Pharmacol. 2021 Nov 23. doi: 10.1097/FJC.0000000000001187. Online ahead of print. J Cardiovasc Pharmacol. 2021. PMID: 34840266
mTOR inhibition as a possible pharmacological target in the management of systemic inflammatory response and associated neuroinflammation by lipopolysaccharide challenge in rats.
Guden DS, Temiz-Resitoglu M, Senol SP, Kibar D, Yilmaz SN, Tunctan B, Malik KU, Sahan-Firat S. Guden DS, et al. Among authors: senol sp. Can J Physiol Pharmacol. 2021 Sep;99(9):921-934. doi: 10.1139/cjpp-2020-0487. Epub 2021 Feb 27. Can J Physiol Pharmacol. 2021. PMID: 33641344
Soluble epoxide hydrolase inhibitor trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl)urea prevents hyperalgesia through regulating NLRC4 inflammasome-related pro-inflammatory and anti-inflammatory signaling pathways in the lipopolysaccharide-induced pain mouse model.
Cagli A, Senol SP, Temiz-Resitoglu M, Guden DS, Sari AN, Sahan-Firat S, Tunctan B. Cagli A, et al. Among authors: senol sp. Drug Dev Res. 2021 Sep;82(6):815-825. doi: 10.1002/ddr.21786. Epub 2021 Feb 8. Drug Dev Res. 2021. PMID: 33559150
Pharmacological inhibition of soluble epoxide hydrolase attenuates chronic experimental autoimmune encephalomyelitis by modulating inflammatory and anti-inflammatory pathways in an inflammasome-dependent and -independent manner.
Biliktu M, Senol SP, Temiz-Resitoglu M, Guden DS, Horat MF, Sahan-Firat S, Sevim S, Tunctan B. Biliktu M, et al. Among authors: senol sp. Inflammopharmacology. 2020 Dec;28(6):1509-1524. doi: 10.1007/s10787-020-00691-w. Epub 2020 Mar 3. Inflammopharmacology. 2020. PMID: 32128702
107 results